30th November 2020
Columbia Threadneedle: Covid-19 vaccines, lockdowns and equities
With the Covid-19 case count rising rapidly across the United States and Europe, the immediate economic outlook associated with renewed lockdowns is turning darker. But announcements from Pfizer and Moderna around the efficacy of their vaccines has cheered financial markets considerably. So how do we approach the possible short-term deterioration in economic data with the greater certainty about the longer-term path to normalisation?
You need to be logged in to comment on this article